The Environmental Law Initiative (ELI) has withdrawn its Court of Appeal challenge against the Environmental Protection Authority (EPA) over glyphosate reassessment in New Zealand.
For some, that may sound like the end of the story.
The EPA welcomed the withdrawal, describing the case as reinforcing confidence in its expert scientists and science-based decision-making. Media headlines quickly framed the development as the conclusion of a long-running legal battle.
But the legal process ending and the scientific debate being resolved are not the same thing.
Because underneath the headlines sits a much larger question New Zealand still hasn’t fully confronted:
Have glyphosate and glyphosate-based herbicides ever undergone a full modern reassessment in New Zealand?
That question remains very much alive.
What Happened in the NZ Glyphosate Appeal?
The Environmental Law Initiative first applied to the EPA in 2023, asking the regulator to determine whether there were grounds to formally reassess glyphosate and glyphosate-based herbicides in New Zealand.
In 2024, the EPA declined the request, stating there was not sufficient new information to justify a reassessment under the Hazardous Substances and New Organisms Act.
ELI then filed for judicial review in the High Court, arguing the EPA had failed to properly consider evolving scientific evidence and broader environmental and public-health concerns.
In October 2025, the High Court ruled in favour of the EPA, finding that ELI had not established a “reviewable error” in the regulator’s decision-making process.
ELI appealed that ruling — but in May 2026, the appeal was withdrawn.
And that distinction matters.
The Court did not rule that glyphosate is unquestionably safe.
It ruled that the EPA had acted within its legal powers and processes.
Those are two very different things.
Why the EPA, ELI, and Media See the Outcome Differently
What makes this story especially interesting is how differently the outcome is being interpreted.
From the EPA’s perspective, the withdrawal reinforces confidence in the current regulatory framework and the agency’s scientific processes.
From a media perspective, the appeal withdrawal can easily sound like closure — another challenge over, another controversy settled.
But ELI’s own framing tells a very different story.
According to ELI, glyphosate and glyphosate-based herbicides have never undergone a full contemporary risk assessment in New Zealand under modern environmental and toxicological standards.
That is not a small claim.
Especially considering how deeply embedded glyphosate-based herbicides have become across farming, public spaces, infrastructure maintenance, and household weed control over the past several decades.
ELI also argues that many co-formulants used in commercial glyphosate-based herbicides have never been comprehensively assessed here, despite some additives facing restrictions or bans overseas.
So while one side sees procedural confirmation, the other sees unresolved scientific and regulatory gaps that still haven’t been meaningfully addressed.
Has Glyphosate Ever Been Fully Reassessed in New Zealand?
One of the most important aspects of this debate is also one of the least understood.
Glyphosate first entered New Zealand long before the EPA existed in its current form and before many modern chemical-risk frameworks were established.
That means aspects of the regulatory foundation surrounding glyphosate were established decades ago — before:
- endocrine disruption became a major research focus,
- formulation toxicity received significant scientific attention,
- long-term low-dose exposure became a central public-health concern,
- and before today’s expectations around transparency and independent reassessment evolved.
This is partly why ELI argued that a full modern reassessment is overdue.
Critics argue that reassessment processes designed around narrow legal thresholds are not necessarily the same thing as a comprehensive modern review of long-term environmental and health impacts. In other words, a regulator may determine there are insufficient legal grounds to formally reopen an assessment, while broader scientific and public-interest questions still remain unresolved.
Not necessarily because every question has already been answered, but because many of the most important questions may never have been fully examined under contemporary standards in the first place.
Glyphosate Is Not the Same Thing as Roundup®
One of the recurring themes throughout the glyphosate debate — both in New Zealand and internationally — is the difference between glyphosate itself and glyphosate-based herbicides as they are actually used in the real world.
The public conversation often treats them as interchangeable.
But they are not technically the same thing.
Commercial formulations contain surfactants, adjuvants, and co-formulants that may alter how the product behaves in plants, soil, water, ecosystems, and potentially the human body.
Some co-formulants historically used in glyphosate-based herbicides have faced restrictions or bans in some overseas jurisdictions.
Yet critics argue that regulatory systems frequently focus heavily on the active ingredient while giving far less scrutiny to full commercial formulations.
That distinction matters because exposure in everyday life does not happen through laboratory-grade glyphosate in isolation.
It happens through mixtures.
And those mixtures can vary significantly between countries, manufacturers, and products.
The Glyphosate Science Debate Is Still Evolving
Even as the legal challenge comes to an end, the broader scientific and regulatory debate around glyphosate continues evolving internationally.
In late 2025, the influential Williams, Kroes & Munro (2000) glyphosate paper — long associated with regulatory reassurance around glyphosate safety — was formally retracted following concerns surrounding undisclosed Monsanto involvement and allegations of ghostwriting.
Whether or not New Zealand regulators relied heavily on that paper specifically, its retraction added to growing international scrutiny around how glyphosate science has been shaped, interpreted, and communicated over the past two decades.
That doesn’t automatically invalidate every regulatory conclusion surrounding glyphosate.
But it does complicate the idea that the science is entirely settled.
And for many members of the public, it reinforces an uncomfortable question:
If cornerstone papers can later unravel, how robust are the foundations beneath long-standing regulatory confidence?
Herbicide Resistance Adds Another Layer to the Debate
What’s also becoming increasingly clear is that glyphosate concerns are no longer limited to health debates.
Agricultural scientists and farming organisations worldwide are now warning about another growing issue: herbicide resistance.
Repeated use of the same herbicide strategies is driving the emergence of resistant weed populations, forcing some growers toward increasingly complex and chemically intensive management systems.
In our recent article, Herbicide Resistance in New Zealand: When Weed Control Stops Working, we explored how this issue may signal something much larger than one chemical alone.
It raises questions about agricultural dependence, system resilience, monoculture vulnerability, and whether modern farming has become structurally tied to chemical solutions that gradually lose effectiveness over time.
That changes the conversation considerably.
Because the glyphosate debate is no longer only:
“Is it safe?”
It is increasingly becoming:
“What happens when entire systems become dependent on it?”
What the Court Case Didn’t Decide About Glyphosate
The withdrawal of the appeal may bring legal closure to this particular case.
But it did not resolve:
- long-term exposure debates,
- endocrine disruption concerns,
- formulation toxicity questions,
- ecological impacts,
- herbicide resistance,
- food-monitoring gaps,
- or broader questions around how New Zealand reassesses legacy chemicals already deeply embedded within society.
Nor did it answer whether current regulatory systems are sufficiently equipped — financially, scientifically, or structurally — to independently revisit decades-old assumptions when new evidence emerges.
Those questions remain, and they are unlikely to disappear simply because a legal pathway has closed.
What This Means for Glyphosate Regulation in New Zealand
The end of the ELI appeal does not mean the glyphosate conversation is over.
If anything, it highlights how much larger the issue has become.
Because this debate is no longer only about one herbicide.
It is increasingly about:
- how modern societies regulate long-standing chemicals,
- how much regulators rely on inherited overseas conclusions,
- how reassessment systems operate,
- how scientific uncertainty is communicated,
- and whether public confidence can survive when the underlying science continues evolving.
The legal chapter may have ended.
But the scientific, environmental, agricultural, and public-interest questions surrounding glyphosate and glyphosate-based herbicides in New Zealand remain very much alive.
And perhaps the biggest question of all is no longer whether glyphosate should be defended or opposed.
It may be whether New Zealand’s regulatory systems are truly capable of revisiting long-standing assumptions at all.
Related Reading
High Court Sides with Environmental Protection Authority on Glyphosate
A breakdown of the original High Court ruling that found the EPA acted within its legal powers when declining to reassess glyphosate. This article explores the gap between procedural legality and the wider public expectation that regulators should continually revisit emerging science and long-term risk.
History Repeating: Why the EPA’s 2025 Legal Battle Feels So Familiar
Part 3 of our glyphosate oversight mini-series examining how the EPA’s current legal defence mirrors concerns raised nearly a decade earlier in the Browning–Brunning review. The article explores regulatory inertia, reliance on overseas assessments, and whether New Zealand’s glyphosate framework has meaningfully evolved.
Glyphosate Study Retraction: The Paper That Wouldn’t Go Away
An investigation into the retraction of the influential Williams, Kroes & Munro (2000) glyphosate paper and why it remained deeply embedded in regulatory discussions for years. The article explores ghostwriting allegations, Monsanto’s involvement, and what happens when cornerstone scientific papers begin to unravel after decades of influence.
Herbicide Resistance in New Zealand: When Weed Control Stops Working
A closer look at the growing issue of herbicide resistance and what it reveals about long-term chemical dependence in modern farming systems. Beyond glyphosate itself, this article explores monocultures, system fragility, and the escalating cycle created when weeds adapt to repeated herbicide use.
Image Source & Attribution
We’re grateful to the talented photographers and designers whose work enhances our content. The feature image on this page is by fokkebok.
